tiprankstipranks
Advertisement
Advertisement

IFRX Stock Latest News

InflaRx upgraded to Strong Buy from Outperform at Raymond James
The FlyInflaRx upgraded to Strong Buy from Outperform at Raymond James
9d ago
IFRX
InflaRx price target raised to $8 from $6 at H.C. Wainwright
PremiumThe Fly
InflaRx price target raised to $8 from $6 at H.C. Wainwright
10d ago
IFRX
InflaRx Raises $150 Million in Underwritten Share Offering Filed in Early May 2026
PremiumCompany Announcements
InflaRx Raises $150 Million in Underwritten Share Offering Filed in Early May 2026
14d ago
6K
IFRX
InflaRx to develop izicopan in AAV
PremiumThe Fly
InflaRx to develop izicopan in AAV
15d ago
IFRX
InflaRx Refocuses Izicopan on Vasculitis and Renal Diseases With Funding Runway to 2029
PremiumCompany Announcements
InflaRx Refocuses Izicopan on Vasculitis and Renal Diseases With Funding Runway to 2029
16d ago
6K
IFRX
InflaRx Files Q1 2026 Financials with SEC via Form 6-K
PremiumCompany AnnouncementsInflaRx Files Q1 2026 Financials with SEC via Form 6-K
16d ago
6K
IFRX
InflaRx Highlights Favorable Safety-Signal Data for Izicopan in New Preclinical Study
Premium
Company Announcements
InflaRx Highlights Favorable Safety-Signal Data for Izicopan in New Preclinical Study
17d ago
6K
IFRX
InflaRx announces new izicopan pre-clinical data
Premium
The Fly
InflaRx announces new izicopan pre-clinical data
18d ago
IFRX
InflaRx Regains Nasdaq Minimum Bid Price Compliance, Securing Listing Status
PremiumCompany Announcements
InflaRx Regains Nasdaq Minimum Bid Price Compliance, Securing Listing Status
23d ago
6K
IFRX
InflaRx assumed with an Outperform at Oppenheimer
PremiumThe Fly
InflaRx assumed with an Outperform at Oppenheimer
28d ago
IFRX
InflaRx Shareholders Approve Capital, Governance Changes and 2026 Incentive Plan at April AGM
PremiumCompany Announcements
InflaRx Shareholders Approve Capital, Governance Changes and 2026 Incentive Plan at April AGM
28d ago
6K
IFRX
InflaRx Highlights New Izicopan Data Showing No CYP3A4 Time-Dependent Inhibition
PremiumCompany Announcements
InflaRx Highlights New Izicopan Data Showing No CYP3A4 Time-Dependent Inhibition
1M ago
6K
IFRX
InflaRx announces new izicopan in vitro findings
PremiumThe FlyInflaRx announces new izicopan in vitro findings
1M ago
IFRX
InflaRx Sets April 23, 2026 AGM to Approve 2025 Accounts, Board Mandates and New LTIP
Premium
Company Announcements
InflaRx Sets April 23, 2026 AGM to Approve 2025 Accounts, Board Mandates and New LTIP
2M ago
6K
IFRX
InflaRx presents vilobelimab data
Premium
The Fly
InflaRx presents vilobelimab data
2M ago
IFRX
InflaRx price target lowered to $14 from $22 at Guggenheim
PremiumThe Fly
InflaRx price target lowered to $14 from $22 at Guggenheim
2M ago
IFRX
InflaRx Shifts Strategy to Izicopan as 2025 Results Extend Cash Runway to 2027
PremiumCompany Announcements
InflaRx Shifts Strategy to Izicopan as 2025 Results Extend Cash Runway to 2027
2M ago
6K
IFRX
InflaRx reports FY25 EPS (EUR 0.68) vs. (EUR 0.78) last year
PremiumThe Fly
InflaRx reports FY25 EPS (EUR 0.68) vs. (EUR 0.78) last year
2M ago
IFRX
IFRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
IFRX Earnings this Week: How Will it Perform?
2M ago
IFRX
InflaRx Cuts Workforce and Refocuses Strategy on Lead Drug Izicopan to Extend Cash Runway to 2027
PremiumCompany AnnouncementsInflaRx Cuts Workforce and Refocuses Strategy on Lead Drug Izicopan to Extend Cash Runway to 2027
4M ago
6K
IFRX
InflaRx: Cost Discipline and Strategic Refocus on Izicopan Underpin Buy Rating
Premium
Ratings
InflaRx: Cost Discipline and Strategic Refocus on Izicopan Underpin Buy Rating
4M ago
IFRX
InflaRx to prioritize izicopan as lead asset, reduces workforce by 30%
Premium
The Fly
InflaRx to prioritize izicopan as lead asset, reduces workforce by 30%
4M ago
IFRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >